TNGX - Tango Therapeutics, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.31
|
Rev Est: $556000
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$19.00
LOW:
$12.00
MEDIAN:
$14.50
CONSENSUS:
$15.00
UPSIDE:
16.46%
Market Cap:
1.42B
Volume:
2,058,063
Avg Volume:
2,861,409
52 Week Range:
1.03-13.48
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.76
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
155
IPO Date:
2020-09-03
EPS (TTM):
-1.19
P/E Ratio:
-2.59
Revenue (TTM):
42.07M
Total Assets:
316.49M
Total Debt:
36.49M
Cash & Equiv:
69.53M
Rev Growth (5Y):
11.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-52.3%
Debt/Equity:
0.18
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $0.13 | $0.01 | +1200.0% | $53.8M | $556000 | +9578.2% |
| 2025-08-05 | $-0.35 | $-0.35 | 0.0% | $3.2M | $6.4M | -50.3% |
| 2025-05-12 | $-0.36 | $-0.34 | -5.9% | $5.4M | $6.4M | -15.2% |
| 2025-02-27 | $-0.35 | $-0.32 | -9.4% | $4.1M | $8.0M | -48.6% |
| 2024-11-06 | $-0.27 | $-0.34 | +20.6% | $11.6M | $8.0M | +44.8% |
| 2024-08-07 | $-0.24 | $-0.34 | +29.4% | $19.9M | $7.4M | +167.9% |
| 2024-05-08 | $-0.35 | $-0.31 | -12.9% | $6.5M | $6.7M | -3.0% |
| 2024-03-18 | $-0.32 | $-0.28 | -14.3% | $5.4M | $8.2M | -34.1% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 42.07M | 36.53M | 24.86M | 37.04M | 7.66M | 24.65M |
| Net Income | (130.30M) | (101.74M) | (108.18M) | (58.23M) | (51.97M) | (14.10M) |
| EPS | -1.19 | -1.08 | -1.23 | -0.94 | -1.62 | -1.57 |
| Total Assets | 316.49M | 402.57M | 436.47M | 500.15M | 207.25M | 55.76M |
| Total Debt | 36.49M | 38.92M | 41.13M | 1.50M | 7.88M | 8.54M |
| Cash & Equivalents | 69.53M | 66.39M | 59.97M | 142.75M | 28.38M | 22.89M |
| Operating Cash Flow | (131.50M) | (117.98M) | (109.08M) | (59.53M) | 70.07M | (24.80M) |
| Free Cash Flow | (132.25M) | (119.51M) | (116.77M) | (61.36M) | 68.97M | (26.62M) |
| FCF per Share | -1.21 | -1.26 | -1.33 | -0.99 | 2.16 | -2.96 |
| Book Value | 199.52M | 253.11M | 249.48M | 344.75M | 38.60M | 7.91M |
| Cash & ST Investments | 257.92M | 336.88M | 366.13M | 485.25M | 190.32M | 40.42M |
| ROC Equity | -0.65 | -0.40 | -0.43 | -0.17 | -1.35 | -1.78 |